Showing results (1531-1540 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|December 21, 2017
Surrogate end points for overall survival in trials of PD-(L)1 inhibitors for urinary cancers: a systematic reviewOmar Abdel-RahmanImmunotherapy|December 21, 2017
PD-1/PD-L1 in diseaseNyanbol Kuol, Lily Stojanovska, Kulmira Nurgali, et al.Immunotherapy|December 21, 2017
Immune-mediated thrombocytopenia and hypothyroidism in a lung cancer patient treated with nivolumabTakanobu Jotatsu, Keishi Oda, Yudai Yamaguchi, et al.Immunotherapy|November 18, 2017
Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancerMartin ReckImmunotherapy|February 1, 2019
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinomaMelissa Bersanelli, Letizia Gnetti, Elena Varotti, et al.Immunotherapy|February 8, 2019
Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case reportMaiko Asai, Yasuhiro Kato, Shoko Kawai, et al.Immunotherapy|February 8, 2019
Fast up-dosing with a birch allergoid is safe and well tolerated in allergic rhinitis patients with or without asthmaStefan Zielen, Kirsten Plückhahn, Yasemin Akboga, et al.Immunotherapy|February 8, 2019
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: a lesson from autoimmune diseasesRossella Talotta, Francesco Rucci, Gianfranco Canti, et al.Immunotherapy|February 8, 2019
Enhancing tumor T cell infiltration to enable cancer immunotherapyJin Zhang, Stefan Endres, Sebastian KoboldImmunotherapy|February 24, 2018
Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?Sabrina Rossi, Giovanna Finocchiaro, Silvia Marchetti, et al.Pageof 190